Clinical Trial Update: The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tranexamic acid for the treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Dyschromicum Perstans
• Lichen Planus Pigmentosus

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Henry Ford Health System | Conditions: Lichen Planus Pigmentosus, Erythema Dyschromicum Perstans | Phase 2 | Status: RECRUITING